Clinical score and rapid antigen detection test to guide antibiotic use for sore throats: randomised controlled trial of PRISM (primary care streptococcal management)BMJ 2018; 360 doi: https://doi.org/10.1136/bmj.k1068 (Published 05 March 2018) Cite this as: BMJ 2018;360:k1068
The authors of this article (BMJ 2013;347:f5806, doi:10.1136/bmj.f5806) have discovered minor errors in the reported complication rates. The article stated that no patients had suppurative complications. In fact, four patients in the first phase of the trial (one in the delayed antibiotic group and three in the clinical score group) and three in the FeverPAIN phase (one in the delayed antibiotic group and two in the antigen test group) had these complications.
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.